RA
ENFN

Royce & Associates’s Enfusion, Inc. ENFN Stock Holding History

Royce & Associates’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-184,078
Closed -$1.9M – 873
2024
Q4 		$1.9M Buy
184,078
+84,363
+85% +$815K 0.02% 637
2024
Q3 		$946K Buy
99,715
+26,045
+35% +$225K 0.01% 735
2024
Q2 		$628K Buy
+73,670
New +$674K 0.01% 772
2023
Q2 		– Sell
-14,300
Closed -$150K – 968
2023
Q1 		$150K Sell
14,300
-27,400
-66% -$302K ﹤0.01% 896
2022
Q4 		$403K Buy
+41,700
New +$470K ﹤0.01% 849

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $514M AUM 4.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $550M AUM 11.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Royce & Associates's ENFN Position: Q1 2025 in Review

Royce & Associates sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 184,078 shares — an estimated $1.9M sold.

Royce & Associates first reported a position in ENFN in Q4 2022 and held it in 5 quarters. The position peaked at $1.9M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Royce & Associates reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Royce & Associates sold 184,078 Enfusion, Inc. shares in Q1 2025, an estimated $1.9M.
  • Royce & Associates first reported a position in Enfusion, Inc. in Q4 2022 and held it in 5 quarters.
  • Royce & Associates's Enfusion, Inc. position peaked at $1.9M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Royce & Associates's 13F filing for Q1 2025, filed 6 May 2025.